Clinical Trial Update: Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of Vitrase for clearing severe vitreous hemorrhage, sponsored by Bausch & Lomb, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• VITRASE (HYALURONIDASE, OVINE)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Vitreous Hemorrhage, Diabetic Retinopathy | Phase 3 | Status: COMPLETED